The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, primarily through its Enhaze platform. This technology, based on the rHuPH20 ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

President Donald Trump's effort to unilaterally wind down the United States Agency for International Development (USAID) has ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with one or more high-risk underlying conditions.

During the COVID-19 pandemic, DTx took on a new lease of life. Many start-up companies used the lenient regulatory environment to pilot new digital tools in various therapeutic fields. Dave ...

While it is increasingly true of DDIs for COVID-19 therapeutics, it is likely that the cytochrome P450 (CYP) enzymes or transporter proteins affecting the pharmacokinetics (PK) or pharmacodynamic (PD) ...